TY - JOUR
T1 - Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins
AU - Woetmann, Anders
AU - Lovato, Paola
AU - Eriksen, Karsten W.
AU - Krejsgaard, Thorbjørn
AU - Labuda, Tord
AU - Zhang, Qian
AU - Mathiesen, Anne Merethe
AU - Geisler, Carsten
AU - Svejgaard, Arne
AU - Wasik, Mariusz A.
AU - Ødum, Niels
PY - 2007/4/15
Y1 - 2007/4/15
N2 - Bacterial toxins including staphylococcal enterotoxins (SEs) have been implicated in the pathogenesis of cutaneous T-cell lymphomas (CTCLs). Here, we investigate SE-mediated interactions between nonmalignant T cells and malignant T-cell lines established from skin and blood of CTCL patients. The malignant CTCL cells express MHC class II molecules that are high-affinity receptors for SE. Although treatment with SE has no direct effect on the growth of the malignant CTCL cells, the SE-treated CTCL cells induce vigorous proliferation of the SE-responsive nonmalignant T cells. In turn, the nonmalignant T cells enhance proliferation of the malignant cells in an SE- and MHC class II-dependent manner. Furthermore, SE and, in addition, alloantigen presentation by malignant CTCL cells to irradiated nonmalignant CD4+ T-cell lines also enhance proliferation of the malignant cells. The growth-promoting effect depends on direct cell-cell contact and soluble factors such as interleukin-2. In conclusion, we demonstrate that SE triggers a bidirectional cross talk between nonmalignant T cells and malignant CTCL cells that promotes growth of the malignant cells. This represents a novel mechanism by which infections with SE-producing bacteria may contribute to pathogenesis of CTCL.
AB - Bacterial toxins including staphylococcal enterotoxins (SEs) have been implicated in the pathogenesis of cutaneous T-cell lymphomas (CTCLs). Here, we investigate SE-mediated interactions between nonmalignant T cells and malignant T-cell lines established from skin and blood of CTCL patients. The malignant CTCL cells express MHC class II molecules that are high-affinity receptors for SE. Although treatment with SE has no direct effect on the growth of the malignant CTCL cells, the SE-treated CTCL cells induce vigorous proliferation of the SE-responsive nonmalignant T cells. In turn, the nonmalignant T cells enhance proliferation of the malignant cells in an SE- and MHC class II-dependent manner. Furthermore, SE and, in addition, alloantigen presentation by malignant CTCL cells to irradiated nonmalignant CD4+ T-cell lines also enhance proliferation of the malignant cells. The growth-promoting effect depends on direct cell-cell contact and soluble factors such as interleukin-2. In conclusion, we demonstrate that SE triggers a bidirectional cross talk between nonmalignant T cells and malignant CTCL cells that promotes growth of the malignant cells. This represents a novel mechanism by which infections with SE-producing bacteria may contribute to pathogenesis of CTCL.
UR - http://www.scopus.com/inward/record.url?scp=34147163008&partnerID=8YFLogxK
U2 - 10.1182/blood-2006-04-017863
DO - 10.1182/blood-2006-04-017863
M3 - Article
C2 - 17179233
AN - SCOPUS:34147163008
SN - 0006-4971
VL - 109
SP - 3325
EP - 3332
JO - Blood
JF - Blood
IS - 8
ER -